Array Biopharma, Inc. (ARRY) Posts Q3 Loss of 20c/Share
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/17/2026
- Generac strikes $8B supply deal with Amazon for data center power
- Wall St ends lower after Fed hikes interest rates, sees more tightening ahead
- Paradium AI (PAAI) Halted, News Pending
- Shipping stocks on fire — but cracks are forming in the rate rally
- JPMorgan Fed scenario analysis: 5 paths for the S&P 500 today
Array Biopharma, Inc. (ARRY) Adds New Director
April 29, 2014 8:08 AM EDTCharles M. Baum, M.D., Ph.D., President and Chief Executive Officer of Mirati Therapeutics, joined Array Biopharma's (Nasdaq: ARRY) board of directors, effective April 25, 2014. Dr. Baum has served as the President and Chief Executive Officer of Mirati since 2012. Previously, he was the Senior... More

